Enteral Feeding Devices Market Assessment, By Product Type [Enteral Feeding Pumps, Enteral Feeding Tubes, Administration Sets, Enteral Syringes, Consumables], By Age Group [Adults, Pediatrics], By Application [Oncology, Gastroenterology, Neurological Diso

Enteral Feeding Devices Market Assessment, By Product Type [Enteral Feeding Pumps, Enteral Feeding Tubes, Administration Sets, Enteral Syringes, Consumables], By Age Group [Adults, Pediatrics], By Application [Oncology, Gastroenterology, Neurological Disorders, Hypermetabolism, Diabetes, Others], By End-user [Hospitals, Home Care Settings, Ambulatory Care Settings], By Region, Opportunities and Forecast, 2017-2031F



Global enteral feeding devices market is projected to witness a CAGR of 5.97% during the forecast period 2024-2031F, growing from USD 4.27 billion in 2023 to USD 6.78 billion in 2031F. The growth of the market is supported by the increasing prevalence of chronic diseases, neurological disorders, and gastrointestinal issues, rising emphasis on novel product launches, and growing popularity of home healthcare.

The growing threat of neurological disorders is one of the leading global enteral feeding devices market trends. According to estimates from the World Health Organization (WHO), in March 2023, every year, there are approximately 10 million new cases of dementia. Dysphagia is common in severe cases of dementia and can often hinder the patient from receiving adequate nutrition. This results in weight loss and malnutrition because of suboptimal oral intake, which often results in increased mortality, morbidity, and disability. Enteral feeding devices provide nutritional support to such patients and ensure that their caloric intake is adequate.

According to estimates of Cancer Research UK, the number of new cases of neck and head cancer in the UK is expected to rise from approximately 14,000 cases in 2023-2025 to 16,300 cases in 2038-2040. This increase is expected to propel the requirement for enteral feeding devices as patients suffering from neck and head cancer have a risk of malnutrition due to the side effects of the radiotherapy treatment that they are receiving for the management of the disease. Enteral feeding devices can provide patients with the necessary vitamins, minerals, proteins, fluids, and calories to aid the patient in fighting infections and maintaining health.

Increasing Prevalence of Diabetes Boosts Market Demand

The rise in diabetes cases in various countries is bolstering the demand for enteral feeding devices globally. As per the estimates of WHO, approximately 422 million individuals across the globe have diabetes. This increase is expected to provide lucrative growth opportunities to the market as enteral feeding devices aid in providing adequate nutrition to the patients and allow them to avoid very low or high blood glucose levels. Enteral feeding devices allow patients with diabetes to receive necessary micro and macronutrients and maintain optimal glycemic control. These devices also eliminate the requirement for frequent hospital visits and allow patients to receive nutrition and manage their glucose levels at home with ease.

Expansion of the Geriatric Population Supports Market Growth

The rapid expansion of the geriatric population is one of the major factors supporting the global enteral feeding devices market growth. As per the estimates of WHO, by 2030 one in six individuals will be 60 or older and by 2050, approximately 2.1 billion individuals will be 60 or older. The older population is susceptible to various diseases and often loses the ability to chew, swallow, or digest food. For instance, elderly patients suffering from severe dementia often develop dysphagia and lose the ability to swallow; this increases their reliance on enteral feeding devices for receiving nutrients. In some cases, the patients are put on ventilators to aid them in breathing and depend on enteral feeding devices. Furthermore, the elderly population is also at high risk of different neurological disorders such as stroke, dementia, and Parkinson’s, among others; these disorders can often hinder the capability of the patient to receive nutrition in the traditional manner, bolstering their reliance on various feeding devices.

North America Accounts for Significant Market Share

The growth of the market in the region is supported by the rising requirement for surgical procedures and the increasing burden of chronic diseases such as cancer and diabetes. According to the estimates of the Public Health Agency of Canada, in 2023, approximately 6% of the adults living in Canada had prediabetes, giving them an increased chance of developing type 2 diabetes.

Other factors aiding the expansion of the market in North America include rising cases of neurological disorders and chronic diseases. Neurological disorders such as Alzheimer’s and Parkinson’s and chronic diseases such as cancer can lead to difficulty in swallowing and effect nutrition absorption and eating habits. Thus, propelling the requirement for enteral feeding devices.

Meanwhile, the growth of older population in the region is also providing lucrative growth opportunities to the market as digestion and dental problems are extremely prominent in the older population and can often prevent them from gaining adequate nutrition, thus increasing their reliance on enteral feeding devices to meet their nutritional requirements. Physical limitations and cognitive decline are other factors that prevent the older population from gaining adequate nutrition as they hinder the body’s ability to manage the intake of fluids and food, augmenting the market’s demand.

Hospitals are Anticipated to Dominate the Market

Rising awareness about hospital-associated malnutrition is one of the major factors supporting the expansion of the segment. Enteral feeding devices allow healthcare professionals to provide nutrition to patients to meet their dietary requirements in cases where the patients are unable to digest or swallow food or absorb nutrition from food.

Additionally, increasing investments in hospital construction and expansion are also augmenting the segment’s growth. In June 2024, the construction of the Critical Service Building of Canberra Hospital reached a new milestone, with the structure reaching 40 meters. The new building, that is a part of the Canberra Hospital Expansion Project, will offer more intensive care beds, operating rooms, and treatment space. Such construction activities will aid hospitals in accommodating more patients, propelling the requirement for enteral feeding devices.

Meanwhile, home care settings are expected to witness significant growth in the coming years. The increasing popularity of the setting can be attributed to the personalized care provided to the patients and technological advancements in telehealth services and remote patient monitoring software and devices. The convenience and comfort provided by home care settings reduce recovery time, further bolstering the popularity of home care settings. Moreover, for patients who require long-term nutritional support enteral feeding devices offer a cost-efficient solution as opposed to hospitalization.

Future Market Scenario (2024-2031F)

According to the global enteral feeding devices market analysis, the demand for enteral feeding devices is expected to significantly increase over the forecast period due to a growing preference for home-based healthcare due to the cost-effective nature of the setting and the convenience and comfort provided by it to both the caretaker and the patient.

Increasing investments by the leading market players in product innovations to ensure the development of feeding devices with sophisticated systems to reduce the risk of complications. The development of smart feeding devices that have sensors for monitoring the condition of the patient and nutrition delivery in real-time is also expected to support the expansion of the market.

Rising emphasis on sustainability by various manufacturers is expected to provide lucrative growth opportunities to the market. Due to increasing concerns about the environment the medical device manufacturing sector is increasingly adopting sustainable production processes and materials to reduce healthcare waste.

Key Players Landscape and Outlook

Novel product launches by key market players are aiding them in expanding their consumer base and bolstering the global market size of enteral feeding devices. In March 2024, Vygon SAS unveiled a new enteral feeding system for neonates called Nutrisafe2. The system ensures feeding safety and precision in neonatal intensive care unit (NICU) and addresses the challenges associated with tubing misconnections, a risk prevalent in neonatal care that often leads to adverse effects such as fatalities. Such developments are expected to provide lucrative growth opportunities to the market in the coming years as they will aid healthcare professionals in increasing patient safety and reducing enteral clinical errors that are caused by misconnections.


1. Research Methodology
2. Project Scope and Definitions
3. Executive Summary
4. Global Enteral Feeding Devices Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1. By Value
4.1.2. By Volume
4.2. By Product Type
4.2.1. Enteral Feeding Pumps
4.2.2. Enteral Feeding Tubes
4.2.3. Administration Sets
4.2.4. Enteral Syringes
4.2.5. Consumables
4.3. By Age Group
4.3.1. Adults
4.3.2. Pediatrics
4.4. By Application
4.4.1. Oncology
4.4.1.1. Liver Cancer
4.4.1.2. Stomach Cancer
4.4.1.3. Pancreatic Cancer
4.4.1.4. Esophageal Cancer
4.4.1.5. Head and Neck Cancer
4.4.1.6. Others
4.4.2. Gastroenterology
4.4.3. Neurological Disorders
4.4.4. Hypermetabolism
4.4.5. Diabetes
4.4.6. Others
4.5. By End-user
4.5.1. Hospitals
4.5.2. Home Care Settings
4.5.3. Ambulatory Care Settings
4.6. By Region
4.6.1. North America
4.6.2. South America
4.6.3. Europe
4.6.4. Asia-Pacific
4.6.5. Middle East & Africa
4.7. By Company Market Share (%), 2023
5. Global Enteral Feeding Devices Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1. Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2. By Product Type
5.1.2.1. Enteral Feeding Pumps
5.1.2.2. Enteral Feeding Tubes
5.1.2.3. Administration Sets
5.1.2.4. Enteral Syringes
5.1.2.5. Consumables
5.1.3. By Age Group
5.1.3.1. Adults
5.1.3.2. Pediatrics
5.1.4. By Application
5.1.4.1. Oncology
5.1.4.1.1. Liver Cancer
5.1.4.1.2. Stomach Cancer
5.1.4.1.3. Pancreatic Cancer
5.1.4.1.4. Esophageal Cancer
5.1.4.1.5. Head and Neck Cancer
5.1.4.1.6. Others
5.1.4.2. Gastroenterology
5.1.4.3. Neurological Disorders
5.1.4.4. Hypermetabolism
5.1.4.5. Diabetes
5.1.4.6. Others
5.1.5. By End-user
5.1.5.1. Hospitals
5.1.5.2. Home Care Settings
5.1.5.3. Ambulatory Care Settings
5.1.6. United States*
5.1.6.1. Market Size & Forecast
5.1.6.1.1. By Value
5.1.6.1.2. By Volume
5.1.6.2. By Product Type
5.1.6.2.1. Enteral Feeding Pumps
5.1.6.2.2. Enteral Feeding Tubes
5.1.6.2.3. Administration Sets
5.1.6.2.4. Enteral Syringes
5.1.6.2.5. Consumables
5.1.6.3. By Age Group
5.1.6.3.1. Adults
5.1.6.3.2. Pediatrics
5.1.6.4. By Application
5.1.6.4.1. Oncology
5.1.6.4.1.1. Liver Cancer
5.1.6.4.1.2. Stomach Cancer
5.1.6.4.1.3. Pancreatic Cancer
5.1.6.4.1.4. Esophageal Cancer
5.1.6.4.1.5. Head and Neck Cancer
5.1.6.4.1.6. Others
5.1.6.4.2. Gastroenterology
5.1.6.4.3. Neurological Disorders
5.1.6.4.4. Hypermetabolism
5.1.6.4.5. Diabetes
5.1.6.4.6. Others
5.1.6.5. By End-user
5.1.6.5.1. Hospitals
5.1.6.5.2. Home Care Settings
5.1.6.5.3. Ambulatory Care Settings
5.1.7. Canada
5.1.8. Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1. Germany
5.2.2. France
5.2.3. Italy
5.2.4. United Kingdom
5.2.5. Russia
5.2.6. Netherlands
5.2.7. Spain
5.2.8. Turkey
5.2.9. Poland
5.3. Asia-Pacific
5.3.1. India
5.3.2. China
5.3.3. Japan
5.3.4. Australia
5.3.5. Vietnam
5.3.6. South Korea
5.3.7. Indonesia
5.3.8. Philippines
5.4. South America
5.4.1. Brazil
5.4.2. Argentina
5.5. Middle East and Africa
5.5.1. Saudi Arabia
5.5.2. UAE
5.5.3. South Africa
6. Market Mapping, 2023
6.1. By Product Type
6.2. By Age Group
6.3. By Application
6.4. By End-user
6.5. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1. Political Factors
7.4.2. Economic System
7.4.3. Social Implications
7.4.4. Technological Advancements
7.4.5. Environmental Impacts
7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1. Supplier Power
7.5.2. Buyer Power
7.5.3. Substitution Threat
7.5.4. Threat From New Entrant
7.5.5. Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. B. Braun SE
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products and Services
13.1.4. Financials (As Reported)
13.1.5. Key Market Focus and Geographical Presence
13.1.6. Recent Developments
13.2. Abbott Healthcare Private Limited
13.3. Boston Scientific Corporation
13.4. Cardinal Health, Inc.
13.5. CONMED Corporation
13.6. Cook Group Incorporated
13.7. Fresenius SE & Co. KGaA
13.8. Becton, Dickinson and Company
13.9. Vygon SAS
13.10. Avanos Medical, Inc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings